⚠ AI Risk Brief Interpretation layer — deterministic data below

STE added business realignment risk and elevated geopolitical and pandemic concerns while removing two acquisition and distributor dependency risks.

Direction ↔ Mixed

ThemesSupply Chain China & Geopolitical Exposure Regulatory & Legal

Classification is based on semantic text similarity scoring and may include approximations. “No match” means no high-confidence textual match was found — not necessarily that a section was removed.

🟢 New in Current Filing Disclosure change7/10

Our business realignment initiatives may not be as successful as anticipated.

Read full text

We execute organizational realignments to support our growth and cost management strategies. We also engage in initiatives aimed to increase productivity, efficiencies and cash flow and to reduce costs. We commit significant resources to identify, develop and retain key employees to maintain uninterrupted leadership and direction. If we are unable to successfully manage these and other organizational changes, the ability to complete such activities and realize anticipated synergies or cost savings as well as our results of operations and financial condition could be materially adversely affected. We cannot offer assurances that any of these initiatives will be beneficial to the extent anticipated, or that the estimated efficiency improvements, incremental cost savings or cash flow improvements will be realized as anticipated or at all.

🟡 Modified The effects of geopolitical instability, including as a result of the Russia-Ukraine and Israel-Hamas military conflicts, may adversely affect us and create significant risks and uncertainties for our business, with the ultimate impact dependent on future developments, which are highly uncertain and unpredictable. 🔒

🔴 No Match in Current Filing Net sales and profitability of our Dental segment are highly dependent on our relationships with a limited number of large distributors. 🔒

🔴 No Match in Current Filing Past and future business acquisitions may not be as accretive to STERIS’s earnings per share and cash flow from operations per share, which may negatively affect the market price of STERIS Shares. 🔒

And 4 more changes in the full comparison.

7 changes in this historical filing

The complete historical comparison (2024 vs 2023) is available on the Pro plan.

Get Pro access Already a Pro subscriber? View full diff →